Based in Australia, Vaxxas is a startup. Brouky records 1 investor associated with the company.
Vaxxas develops and commercialises needle-free vaccine delivery technology to administer vaccines without traditional needles, aiming to simplify vaccine administration and improve immunisation delivery.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.